Skip to main content
Erschienen in: Breast Cancer Research and Treatment 3/2012

01.10.2012 | Clinical trial

Predicting sentinel lymph node metastasis in a Chinese breast cancer population: assessment of an existing nomogram and a new predictive nomogram

verfasst von: Jia-ying Chen, Jia-jian Chen, Ben-long Yang, Zhe-bin Liu, Xiao-yan Huang, Guang-yu Liu, Qi-xia Han, Wen-tao Yang, Zhen-zhou Shen, Zhi-min Shao, Jiong Wu

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

We assessed the MSKCC nomogram performance in predicting SLN metastases in a Chinese breast cancer population. A new model (the SCH nomogram) was developed with clinically relevant variables and possible advantages. Data were collected from 1,545 patients who had a successful SLN biopsy between March 2005 and November 2011. We validated the MSKCC nomogram in the modeling and validation group. Clinical and pathologic features of SLN biopsy in modeling group of 1,000 patients were assessed with multivariable logistic regression to predict the presence of SLN metastasis in breast cancer. The SCH nomogram was created from the logistic regression model and subsequently applied to 545 consecutive SLN biopsies. By multivariate analysis, age, tumor size, tumor location, tumor type, and lymphovascular invasion were identified as independent predictors of SLN metastasis. The SCH nomogram was then developed using the five variables. The new model was accurate and discriminating (with an AUC of 0.7649 in the modeling group) compared to the MSKCC nomogram (with an AUC of 0.7105 in the modeling group). The area under the ROC curve for the SCH nomogram in the validation population is 0.7587. The actual probability trends for the various deciles were comparable to the predicted probabilities. The false-negative rates of the SCH nomogram were 1.67, 3.54, and 8.20 % for the predicted probability cut-off points of 5, 10, and 15 %, respectively. Compared with the MSKCC nomogram, the SCH nomogram has a better AUC with fewer variables and has lower false-negative rates for the low-probability subgroups. The SCH nomogram could serve as a more acceptable clinical tool in preoperative discussions with patients, especially very-low-risk patients. When applied to these patients, the SCH nomogram could be used to safely avoid a SLN procedure. The nomogram should be validated in various patient populations to demonstrate its reproducibility.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Krag DN, Anderson SJ, Julian TB et al (2007) Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 8:881–888PubMedCrossRef Krag DN, Anderson SJ, Julian TB et al (2007) Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 8:881–888PubMedCrossRef
2.
Zurück zum Zitat Mansel RE, Fallowfield L, Kissin M et al (2006) Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 98:599–609PubMedCrossRef Mansel RE, Fallowfield L, Kissin M et al (2006) Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 98:599–609PubMedCrossRef
3.
Zurück zum Zitat Veronesi U, Paganelli G, Viale G et al (2006) Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol 7:983–990PubMedCrossRef Veronesi U, Paganelli G, Viale G et al (2006) Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol 7:983–990PubMedCrossRef
4.
Zurück zum Zitat Purushotham AD, Upponi S, Klevesath MB, Bobrow L, Millar K, Myles JP, Duffy SW (2005) Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. J Clin Oncol 23:4312–4321PubMedCrossRef Purushotham AD, Upponi S, Klevesath MB, Bobrow L, Millar K, Myles JP, Duffy SW (2005) Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. J Clin Oncol 23:4312–4321PubMedCrossRef
5.
Zurück zum Zitat Del Bianco P, Zavagno G, Burelli P et al (2008) Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella–GIVOM Italian randomised clinical trial. EJSO 34:508–513PubMedCrossRef Del Bianco P, Zavagno G, Burelli P et al (2008) Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella–GIVOM Italian randomised clinical trial. EJSO 34:508–513PubMedCrossRef
6.
Zurück zum Zitat Baron RH, Fey JV, Borgen PI, Stempel MM, Hardick KR, Van Zee KJ (2007) Eighteen sensations after breast cancer surgery: a 5-year comparison of sentinel lymph node biopsy and axillary lymph node dissection. Ann Surg Oncol 14:1653–1661PubMedCrossRef Baron RH, Fey JV, Borgen PI, Stempel MM, Hardick KR, Van Zee KJ (2007) Eighteen sensations after breast cancer surgery: a 5-year comparison of sentinel lymph node biopsy and axillary lymph node dissection. Ann Surg Oncol 14:1653–1661PubMedCrossRef
7.
Zurück zum Zitat Bevilacqua JL, Kattan MW, Fey JV, Cody HS 3rd, Borgen PI, Van Zee KJ (2007) Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation. J Clin Oncol 25:3670–3679PubMedCrossRef Bevilacqua JL, Kattan MW, Fey JV, Cody HS 3rd, Borgen PI, Van Zee KJ (2007) Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation. J Clin Oncol 25:3670–3679PubMedCrossRef
8.
Zurück zum Zitat Klar M, Foeldi M, Markert S, Gitsch G, Stickeler E, Watermann D (2008) Good prediction of the likelihood for sentinel lymph node metastasis by using the MSKCC nomogram in a German breast cancer population. Ann Surg Oncol 16:1136–1142CrossRef Klar M, Foeldi M, Markert S, Gitsch G, Stickeler E, Watermann D (2008) Good prediction of the likelihood for sentinel lymph node metastasis by using the MSKCC nomogram in a German breast cancer population. Ann Surg Oncol 16:1136–1142CrossRef
9.
Zurück zum Zitat Carter CL, Allen C, Henderson DE (1989) Relation of tumour size, lymph node status and survival in 24, 740 breast cancer cases. Cancer 63:181–187PubMedCrossRef Carter CL, Allen C, Henderson DE (1989) Relation of tumour size, lymph node status and survival in 24, 740 breast cancer cases. Cancer 63:181–187PubMedCrossRef
10.
Zurück zum Zitat Rosen PP, Groshen S, Saigo PE, Kinne DW, Hellman S (1989) Pathologic prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow up of 18 years. J Clin Oncol 7:1239–1251PubMed Rosen PP, Groshen S, Saigo PE, Kinne DW, Hellman S (1989) Pathologic prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow up of 18 years. J Clin Oncol 7:1239–1251PubMed
11.
Zurück zum Zitat Quiet CA, Ferguson DJ, Weichselbaum RR, Hellman S (1995) Natural history of node-negative breast cancer: a study of 826 patients with long-term follow-up. J Clin Oncol 13:1144–1151PubMed Quiet CA, Ferguson DJ, Weichselbaum RR, Hellman S (1995) Natural history of node-negative breast cancer: a study of 826 patients with long-term follow-up. J Clin Oncol 13:1144–1151PubMed
12.
Zurück zum Zitat Barranger E, Coutant C, Flahault A et al (2005) An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement. Breast Cancer Res Treat 91:113–119PubMedCrossRef Barranger E, Coutant C, Flahault A et al (2005) An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement. Breast Cancer Res Treat 91:113–119PubMedCrossRef
13.
Zurück zum Zitat Pal A, Provenzano E, Duffy SW, Pinder SE, Purushotham AD (2008) A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive. Br J Surg 95:302–309PubMedCrossRef Pal A, Provenzano E, Duffy SW, Pinder SE, Purushotham AD (2008) A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive. Br J Surg 95:302–309PubMedCrossRef
14.
Zurück zum Zitat Kohrt HE, Olshen RA, Bermas HR et al (2008) New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients. BMC Cancer 8:66PubMedCrossRef Kohrt HE, Olshen RA, Bermas HR et al (2008) New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients. BMC Cancer 8:66PubMedCrossRef
15.
Zurück zum Zitat Van Zee KJ, Manasseh DM, Bevilacqua JL et al (2003) A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 10:1140–1151PubMedCrossRef Van Zee KJ, Manasseh DM, Bevilacqua JL et al (2003) A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 10:1140–1151PubMedCrossRef
16.
Zurück zum Zitat Katz A, Smith BL, Golshan M et al (2008) Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer. J Clin Oncol 26:2093–2098PubMedCrossRef Katz A, Smith BL, Golshan M et al (2008) Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer. J Clin Oncol 26:2093–2098PubMedCrossRef
17.
Zurück zum Zitat Degnim AC, Reynolds C, Pantvaidya G et al (2005) Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram. Am J Surg 190:543–550PubMedCrossRef Degnim AC, Reynolds C, Pantvaidya G et al (2005) Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram. Am J Surg 190:543–550PubMedCrossRef
18.
Zurück zum Zitat Kocsis L, Svébis M, Boross G, Sinkό M, Maráz R, Rajtár M, Cserni G (2004) Use and limitations of a nomogram predicting the likelihood of non-sentinel node involvement after a positive sentinel node biopsy in breast cancer patients. Am Surg 70:1019–1024PubMed Kocsis L, Svébis M, Boross G, Sinkό M, Maráz R, Rajtár M, Cserni G (2004) Use and limitations of a nomogram predicting the likelihood of non-sentinel node involvement after a positive sentinel node biopsy in breast cancer patients. Am Surg 70:1019–1024PubMed
19.
Zurück zum Zitat Alran S, De Rycke Y, Fourchotte V et al (2007) Institute Curie Breast Cancer Study Group Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy. Ann Surg Oncol 14:2195–2201PubMedCrossRef Alran S, De Rycke Y, Fourchotte V et al (2007) Institute Curie Breast Cancer Study Group Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy. Ann Surg Oncol 14:2195–2201PubMedCrossRef
20.
Zurück zum Zitat Klar M, Jochmann A, Foeldi M, Stumpf M, Gitsch G, Stickeler E et al (2008) The MSKCC nomogram for prediction the likelihood of non-sentinel node involvement in a German breast cancer population. Breast Cancer Res Treat 112:523–531PubMedCrossRef Klar M, Jochmann A, Foeldi M, Stumpf M, Gitsch G, Stickeler E et al (2008) The MSKCC nomogram for prediction the likelihood of non-sentinel node involvement in a German breast cancer population. Breast Cancer Res Treat 112:523–531PubMedCrossRef
21.
Zurück zum Zitat Cserni G (2005) Evaluation of sentinel lymph nodes in breast cancer. Histopathology 46:697–706PubMedCrossRef Cserni G (2005) Evaluation of sentinel lymph nodes in breast cancer. Histopathology 46:697–706PubMedCrossRef
22.
Zurück zum Zitat Cserni G, Amendoeira I, Apostolikas N et al (2004) Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of questionnaire-based survey by the European Working Gourp for Breast Screening Pathology. J Clin Pathol 57:695–701PubMedCrossRef Cserni G, Amendoeira I, Apostolikas N et al (2004) Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of questionnaire-based survey by the European Working Gourp for Breast Screening Pathology. J Clin Pathol 57:695–701PubMedCrossRef
23.
Zurück zum Zitat Weaver DL, Ashikaga T, Krag DN et al (2011) Effect of occult metastases on survival in node-negative breast cancer. N Engl J Med 364:412–421PubMedCrossRef Weaver DL, Ashikaga T, Krag DN et al (2011) Effect of occult metastases on survival in node-negative breast cancer. N Engl J Med 364:412–421PubMedCrossRef
24.
Zurück zum Zitat Cserni G, Gregori D, Merletti F et al (2004) Non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer: metaanalysis of 25 studies. Br J Surg 91:1245–1252PubMedCrossRef Cserni G, Gregori D, Merletti F et al (2004) Non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer: metaanalysis of 25 studies. Br J Surg 91:1245–1252PubMedCrossRef
25.
Zurück zum Zitat Chen SL, Hoehne FM, Giuliano AE (2007) The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis. Ann Surg Oncol 14:3378–3384PubMedCrossRef Chen SL, Hoehne FM, Giuliano AE (2007) The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis. Ann Surg Oncol 14:3378–3384PubMedCrossRef
26.
Zurück zum Zitat Cserni G, Amendoeira I, Apostolikas N et al (2003) Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines. Eur J Cancer 39:1654–1667PubMedCrossRef Cserni G, Amendoeira I, Apostolikas N et al (2003) Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines. Eur J Cancer 39:1654–1667PubMedCrossRef
27.
Zurück zum Zitat Fan L, Zheng Y, Yu KD et al (2009) Breast cancer in a transitional society over 18 years: trends and present status in Shanghai, China. Breast Cancer Res Treat 117:409–416PubMedCrossRef Fan L, Zheng Y, Yu KD et al (2009) Breast cancer in a transitional society over 18 years: trends and present status in Shanghai, China. Breast Cancer Res Treat 117:409–416PubMedCrossRef
28.
Zurück zum Zitat American Cancer Society (2007) Breast cancer facts and figures 2007–2008. American Cancer Society Inc, Atlanta American Cancer Society (2007) Breast cancer facts and figures 2007–2008. American Cancer Society Inc, Atlanta
29.
Zurück zum Zitat Son BH, Kwak BS, Kim JK et al (2006) Changing patterns in the clinical characteristics of Korean patients with breast cancer during the last 15 years. Arch Surg 141:155–160 Son BH, Kwak BS, Kim JK et al (2006) Changing patterns in the clinical characteristics of Korean patients with breast cancer during the last 15 years. Arch Surg 141:155–160
30.
Zurück zum Zitat Lyman GH, Guiliano AE, Somerfield MR et al (2005) The Americal Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early stage breast cancer. J Clin Oncol 23:7703–7720PubMedCrossRef Lyman GH, Guiliano AE, Somerfield MR et al (2005) The Americal Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early stage breast cancer. J Clin Oncol 23:7703–7720PubMedCrossRef
31.
Zurück zum Zitat Giuliano AE, Hunt KK, Ballman KV et al (2011) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305:569–575PubMedCrossRef Giuliano AE, Hunt KK, Ballman KV et al (2011) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305:569–575PubMedCrossRef
32.
Zurück zum Zitat Sakorafas GH, Peros G, Cataliotti L, Vlastos G (2006) Lymphedema following axillary lymph node dissection for breast cancer. Surg Oncol 15:153–165PubMedCrossRef Sakorafas GH, Peros G, Cataliotti L, Vlastos G (2006) Lymphedema following axillary lymph node dissection for breast cancer. Surg Oncol 15:153–165PubMedCrossRef
33.
Zurück zum Zitat della Rovere GQ, Bonomi R, Ashley S, Benson JR (2006) Axillary staging in women with small invasive breast tumours. Eur J Surg Oncol 32:733–737PubMedCrossRef della Rovere GQ, Bonomi R, Ashley S, Benson JR (2006) Axillary staging in women with small invasive breast tumours. Eur J Surg Oncol 32:733–737PubMedCrossRef
Metadaten
Titel
Predicting sentinel lymph node metastasis in a Chinese breast cancer population: assessment of an existing nomogram and a new predictive nomogram
verfasst von
Jia-ying Chen
Jia-jian Chen
Ben-long Yang
Zhe-bin Liu
Xiao-yan Huang
Guang-yu Liu
Qi-xia Han
Wen-tao Yang
Zhen-zhou Shen
Zhi-min Shao
Jiong Wu
Publikationsdatum
01.10.2012
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 3/2012
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-012-2219-x

Weitere Artikel der Ausgabe 3/2012

Breast Cancer Research and Treatment 3/2012 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.